These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Combination antifungal therapy with voriconazole for persistent candidemia in very low birth weight neonates. Turan O; Ergenekon E; Hirfanoğlu IM; Onal EE; Baş VN; Türkyilmaz C; Koç E; Atalay Y Turk J Pediatr; 2011; 53(1):19-26. PubMed ID: 21534335 [TBL] [Abstract][Full Text] [Related]
3. Voriconazole for candidosis: an important addition? Graybill JR Lancet; 2005 Oct 22-28; 366(9495):1413-4. PubMed ID: 16243074 [No Abstract] [Full Text] [Related]
4. Severe Candida albicans panophthalmitis treated with all available and potentially effective antifungal drugs: fluconazole, liposomal amphotericin B, caspofungin, and voriconazole. Manfredi R; Sabbatani S Scand J Infect Dis; 2006; 38(10):950-1. PubMed ID: 17008248 [TBL] [Abstract][Full Text] [Related]
5. Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial. Kullberg BJ; Sobel JD; Ruhnke M; Pappas PG; Viscoli C; Rex JH; Cleary JD; Rubinstein E; Church LW; Brown JM; Schlamm HT; Oborska IT; Hilton F; Hodges MR Lancet; 2005 Oct 22-28; 366(9495):1435-42. PubMed ID: 16243088 [TBL] [Abstract][Full Text] [Related]
6. Voriconazole: new preparation. Invasive aspergillosis: benefits to be confirmed. Prescrire Int; 2004 Feb; 13(69):13-6. PubMed ID: 15055210 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of triazoles in a murine disseminated infection by Candida krusei. Mariné M; Pastor FJ; Serena C; Guarro J Antimicrob Agents Chemother; 2009 Aug; 53(8):3585-8. PubMed ID: 19470509 [TBL] [Abstract][Full Text] [Related]
8. Antifungal activity of voriconazole (UK-109,496), fluconazole and amphotericin B against hematogenous Candida krusei infection in neutropenic guinea pig model. Ghannoum MA; Okogbule-Wonodi I; Bhat N; Sanati H J Chemother; 1999 Feb; 11(1):34-9. PubMed ID: 10078778 [TBL] [Abstract][Full Text] [Related]
9. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. Walsh TJ; Pappas P; Winston DJ; Lazarus HM; Petersen F; Raffalli J; Yanovich S; Stiff P; Greenberg R; Donowitz G; Schuster M; Reboli A; Wingard J; Arndt C; Reinhardt J; Hadley S; Finberg R; Laverdière M; Perfect J; Garber G; Fioritoni G; Anaissie E; Lee J; N Engl J Med; 2002 Jan; 346(4):225-34. PubMed ID: 11807146 [TBL] [Abstract][Full Text] [Related]
10. Management of endogenous fungal endophthalmitis with voriconazole and caspofungin. Breit SM; Hariprasad SM; Mieler WF; Shah GK; Mills MD; Grand MG Am J Ophthalmol; 2005 Jan; 139(1):135-40. PubMed ID: 15652837 [TBL] [Abstract][Full Text] [Related]
11. Candidaemia secondary to intravascular catheter colonisation? Bal AM Lancet; 2006 Mar; 367(9512):728-9; author reply 729. PubMed ID: 16517269 [No Abstract] [Full Text] [Related]
12. [Conservative management with new antifungals in a case of Candida prosthetic valve endocarditis]. Piñar D; Reus S; Pérez P; Quiles JA Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):66-7. PubMed ID: 19419799 [No Abstract] [Full Text] [Related]
13. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies. Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613 [TBL] [Abstract][Full Text] [Related]
14. Caspofungin for the treatment of azole resistant candidemia in a premature infant. Smith PB; Steinbach WJ; Cotten CM; Schell WA; Perfect JR; Walsh TJ; Benjamin DK J Perinatol; 2007 Feb; 27(2):127-9. PubMed ID: 17262048 [TBL] [Abstract][Full Text] [Related]